Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Morgan Stanley and PSAM Launch UCITS III Fund

Monday, August 16, 2010
Opalesque Industry Update - Morgan Stanley (NYSE: MS) announced that it has launched its first UCITS III Fund on the Firm’s FundLogic platform managed by an alternative manager. This fund will be managed by P.Schoenfeld Asset Management LP (PSAM) and will offer exposure to a global event-driven investment strategy.

Commenting on the new fund launch, Shahzad Sadique, Executive Director and Head of FundLogic at Morgan Stanley said, “we are seeing a huge level of interest from investors to access alternative asset manager expertise through UCITS Funds and are delighted that PSAM has partnered with Morgan Stanley. We are currently seeking regulatory approval for a number of funds managed by leading alternative asset managers and look forward to launching more UCITS funds on FundLogic in the next few months.”

“Our UCITS fund will provide investors with access to a global event-driven strategy which includes mergers and acquisitions, stressed and distressed credit and special situations strategies, while providing them with greater liquidity and transparency – attributes we believe will make the fund attractive to new types of investors,” commented Peter Schoenfeld, Chairman and CEO of PSAM. “We have a long relationship with Morgan Stanley dating back to PSAM’s inception in 1997 and it is the logical partner for us on this exciting new product given the strength of its platform and the track record of success we have working together.”

FundLogic is the brand name for Morgan Stanley’s Structured Fund platform, which was set up in 2006 as a multi asset platform. It can offer both UCITS III and non-UCITS Funds on a global basis. The platform delivers fund solutions to clients by combining the financial expertise, creativity and resources from Morgan Stanley and can offer products ranging from simple Index

Funds through to complex investment solutions for institutions.

Fund Details:
Fund Name: MS PSAM Global Event UCITS
Umbrella Fund: FundLogic Alternatives Plc
Funds domicile: Ireland
Investment Manager: P.Schoenfeld Asset Management (PSAM)
Promoter: Morgan Stanley International Plc
Dealing: Weekly dealing (Every Friday)
Custodian: Northern Trust Fiduciary Services (Ireland) Limited
Administrator: Northern Trust International Fund Administration Services (Ireland) Limited
Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its